A Novel Selective JAK2 Inhibitor Identified Using Pharmacological Interactions
Sign Up to like & getrecommendations! Published in 2018 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2018.01379
Abstract: The JAK2/STAT signaling pathway mediates cytokine receptor signals that are involved in cell growth, survival and homeostasis. JAK2 is a member of the Janus kinase (JAK) family and aberrant JAK2/STAT is involved with various diseases,… read more here.
Keywords: inhibitor; compound nsc13626; pharmacological interactions; selective jak2 ... See more keywords